CCR5 Ligands in HIV Vaccines

responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. J
Virol 1998;72:876-881.
23. Scala E, et al. C-C chemokines, IL-16, and soluble antiviral factor activity are
increased in cloned T cells from subjects with long-term nonprogressive HIV
infection. J Immunol 1997;158:4485-4492.
24. Rosenberg ES, et al. Vigorous HIV-1-specific CD4+ T cell responses associated
with control of viremia. Science 1997;278:1447-1450.
25. Aukrust P, Muller F, Froland SS. Circulating levels of RANTES in human
immunodeficiency virus type 1 infection: effect of potent antiretroviral therapy. J
Infect Dis 1998;177:1091-1096.
26. Zagury D, et al.. Interferon c and Tat involvement in the immunosuppression of
uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci USA
1998;95:3851-3856. Tartakovsky B, Turner D, Vardinon N, Burke M, Yust I.
Increased intracellular accumulation of macrophage inflammatory protein 1 j3 and its
decreased secretion correlate with advanced HIV disease. J Acquir Immune Defic
Syndr Hum Retrovirol 1999;20:420-422.
27. Fransen S, Copeland KF, Smieja M, Smaill F, Rosenthal KL. RANTES production
by T cells and CD8-mediated inhibition of human immunodeficiency virus gene
expression before initiation of potent antiretroviral therapy predict sustained
suppression of viral replication. J Infect Dis 2000;181:505-512.
28. Garzino-Demo A, Moss RB, Margolick JB, Cleghorn F, Sill A, Blattner WA,
Cocchi F, Carlo DJ, DeVico AL, Gallo RC. Spontaneous and antigen-induced
production of HIV-inhibitory beta-chemokines are associated with AIDS-free
status. Proc Natl Acad Sci US A. 1999 96:11986-11991.
29. Cocchi F, DeVico AL, Yarchoan R, Redfield R, Cleghorn F, Blattner WA, GarzinoDemo A, Colombini-Hatch S, Margolis D, Gallo RC. Higher macrophage
inflammatory protein (MIP)-lalpha and MIP-ibeta levels from CD8+ T cells are
associated with asymptomatic HIV-1 infection. HIV-1 infection. Proc. Natl Acad
Sci U S A. 2000 Dec 5;97(25):13812-13817.
30. Dean M, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a
deletion allele of the CKR5 structural gene. Science 1996;273:1856-1862.
31. Samson M, et al. Resistance to HIV-1 infection in Caucasian individuals bearing
mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-725.
32. Huang Y, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease
progression. Nature Med 1 996;2:1240-1243.
33. Liu R, et at. Homozygous defect in HIV-1 coreceptor accounts for resistance of
some multiply-exposed individuals to 11W-i infection. Cell 1996;86:367-377.
34. Michael NE, et at. The role of viral phenotype and CCR-5 gene defects in HWV-1
transmission and disease progression. Nature Med 1997;3:338-340.
35. Zimmerman PA,, et at. Inherited resistance to 11W-i conferred by an inactivating
mutation in CC chemokine receptor-S-studies in populations with contrasting

12